Table 3. Multiple factor analysis of NCAM1 related pathway mutations and clinical parameters per tumour.
Dim.1 | Dim.2 | Dim.3 | Dim.4 | Dim.5 | |
---|---|---|---|---|---|
A. No. Mutations in NCAM Pathways* | 0.103 | 0.892 | 0.910 | 0.367 | 0.321 |
Stages | 0.804 | 0.459 | 0.381 | 0.833 | 0.725 |
Receptor status | 0.379 | 0.356 | 0.406 | 0.471 | 0.641 |
Patient status | 0.868 | 0.159 | 0.050 | 0.106 | 0.159 |
% Variance explained | 7.618 | 5.699 | 5.635 | 4.944 | 4.694 |
B. No. Mutations Unique to NCAM Pathways∧ | 0.264 | 0.899 | 0.894 | 0.304 | 0.300 |
Stage | 0.791 | 0.413 | 0.380 | 0.877 | 0.752 |
Receptor status | 0.389 | 0.427 | 0.411 | 0.429 | 0.610 |
Patient status | 0.851 | 0.083 | 0.158 | 0.168 | 0.221 |
% Variance explained | 7.716 | 5.816 | 5.534 | 4.941 | 4.743 |
*mutation count for all genes in NCAM pathways.
∧mutation count for genes unique to NCAM pathways, and not in collagen or ECM pathways.